Cargando…
Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Massachusetts Medical Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511631/ https://www.ncbi.nlm.nih.gov/pubmed/36121928 http://dx.doi.org/10.1056/NEJMc2209952 |
| _version_ | 1784797680011051008 |
|---|---|
| author | Takashita, Emi Yamayoshi, Seiya Fukushi, Shuetsu Suzuki, Tadaki Maeda, Ken Sakai-Tagawa, Yuko Ito, Mutsumi Uraki, Ryuta Halfmann, Peter Watanabe, Shinji Takeda, Makoto Hasegawa, Hideki Imai, Masaki Kawaoka, Yoshihiro |
| author_facet | Takashita, Emi Yamayoshi, Seiya Fukushi, Shuetsu Suzuki, Tadaki Maeda, Ken Sakai-Tagawa, Yuko Ito, Mutsumi Uraki, Ryuta Halfmann, Peter Watanabe, Shinji Takeda, Makoto Hasegawa, Hideki Imai, Masaki Kawaoka, Yoshihiro |
| author_sort | Takashita, Emi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9511631 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Massachusetts Medical Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95116312022-10-05 Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75 Takashita, Emi Yamayoshi, Seiya Fukushi, Shuetsu Suzuki, Tadaki Maeda, Ken Sakai-Tagawa, Yuko Ito, Mutsumi Uraki, Ryuta Halfmann, Peter Watanabe, Shinji Takeda, Makoto Hasegawa, Hideki Imai, Masaki Kawaoka, Yoshihiro N Engl J Med Correspondence Massachusetts Medical Society 2022-09-07 /pmc/articles/PMC9511631/ /pubmed/36121928 http://dx.doi.org/10.1056/NEJMc2209952 Text en Copyright © 2022 Massachusetts Medical Society. All rights reserved. http://www.nejmgroup.org/legal/terms-of-use.htm This article is made available via the PMC Open Access Subset for unrestricted re-use, except commercial resale, and analyses in any form or by any means with acknowledgment of the original source. PMC is granted a license to make this article available via PMC and Europe PMC, subject to existing copyright protections. |
| spellingShingle | Correspondence Takashita, Emi Yamayoshi, Seiya Fukushi, Shuetsu Suzuki, Tadaki Maeda, Ken Sakai-Tagawa, Yuko Ito, Mutsumi Uraki, Ryuta Halfmann, Peter Watanabe, Shinji Takeda, Makoto Hasegawa, Hideki Imai, Masaki Kawaoka, Yoshihiro Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75 |
| title | Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75 |
| title_full | Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75 |
| title_fullStr | Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75 |
| title_full_unstemmed | Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75 |
| title_short | Efficacy of Antiviral Agents against the Omicron Subvariant BA.2.75 |
| title_sort | efficacy of antiviral agents against the omicron subvariant ba.2.75 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511631/ https://www.ncbi.nlm.nih.gov/pubmed/36121928 http://dx.doi.org/10.1056/NEJMc2209952 |
| work_keys_str_mv | AT takashitaemi efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT yamayoshiseiya efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT fukushishuetsu efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT suzukitadaki efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT maedaken efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT sakaitagawayuko efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT itomutsumi efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT urakiryuta efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT halfmannpeter efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT watanabeshinji efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT takedamakoto efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT hasegawahideki efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT imaimasaki efficacyofantiviralagentsagainsttheomicronsubvariantba275 AT kawaokayoshihiro efficacyofantiviralagentsagainsttheomicronsubvariantba275 |